Strata Critical Medical Q2 revenue $72.5M (+60.7% YoY); net loss $(10.5)M

Strata Critical Medical, Inc.

Revenue $72.5M, up 60.7% YoY; Clinical segment contributed $24.3M vs. zero in prior year.
Net loss from continuing ops $(10.5)M (14.5% of revenue) vs. $(3.4)M loss a year ago.
Adjusted EBITDA $7.9M (10.9% margin); operating cash flow $5.7M, free cash flow $2.9M.
Completed bolt-on acquisitions of Louisville Perfusion, Heart/Lung Transplant Recovery, Ohio Valley Perfusion in Q2.
Signed agreement to take over Statline's Transplant Center Organ Placement customer relationships over next year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.